[Renin-angiotensin system and insulin resistance: carbohydrate-metabolism disorders].
Shimamoto
Kazuaki
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D003920:Diabetes Mellitus / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000209:etiology / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D014409:Tumor Necrosis Factor-alpha